Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
A novel gene therapy that leads to cellular rejuvenation could restore vision after non-arteritic anterior ischemic optic neuropathy (NAION) and glaucoma. The technique is based on a reprogramming ...
Aging—the progressive decline in our physiological function as we get older—is something many of us hope to slow, stop, or even reverse. Of course, this process is inevitable and something we cannot ...
These data, along with additional ER-100 preclinical data from a nonhuman primate model of NAION demonstrating clear restoration of methylation patterns with functional enrichment of neuronal ...
BOSTON, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company advancing innovative cellular rejuvenation technologies to reverse diseases of aging and injury and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results